Cardiology of the future: xenotransplantation with porcine heart
- PMID: 36380793
- PMCID: PMC9653127
- DOI: 10.1093/eurheartjsupp/suac107
Cardiology of the future: xenotransplantation with porcine heart
Abstract
The reduced availability of human donor hearts compared with the needs of patients with advanced heart failure refractory to medical therapy has promoted the search for therapeutic alternatives to cardiac allografts. Porcine heart xenotransplantation represents one of the most promising frontiers in this field today. From the first researches in the 1960s to today, the numerous advances achieved in the field of surgical techniques, genetic engineering and immunosuppression have made it possible at the beginning of 2022 to carry out the first swine-to-human heart transplant, attaining a survival of 2 months after surgery. The main intellectual and experimental stages that have marked the history of xenotransplantation, the latest acquisitions in terms of genetic editing, as well as the improvement of immunosuppressive therapy are discussed analytically in this article in order to illustrate the underlying complexity of this therapeutic model.
Keywords: Genetic engineering; Heart failure refractory to medical therapy; Heart xenotransplantation.
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: None declared.
Figures
References
-
- Lund LH, Edwards LB, Kucheryavaya AYet al. . The registry of the international society for heart and lung transplantation: thirtieth official adult heart transplant report–2013; focus theme: age. J Heart Lung Transplant 2013;32:951–164 . - PubMed
-
- McDonagh TA, Metra M, Adamo Met al. . ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 2021;42:4901. - PubMed
-
- DeFilippis EM, Clerkin K, Truby LKet al. . ECMO As a bridge to left ventricular assist device or heart transplantation. JACC Heart Fail 2021;9:281–289. - PubMed
-
- Centro Nazionale Trapianti . Donazione & trapianto di organi, tessuti e cellule staminali emopoietiche; Valutazione di qualità dell'attività del trapianto di cuore 2000–2018; Attività annuale Rete Nazionale Trapianti. Report 2020; Regolamento delle urgenze di cuore in ambito nazionale e di macroarea. Available online at: https://www.trapianti.salute.gov.it.
-
- Shu S, Ren J, Song J. Cardiac xenotransplantation: a promising way to treat advanced heart failure. Heart Fail Rev 2022;27:71–91. - PubMed
LinkOut - more resources
Full Text Sources